FDA clears next-gen image viewer from GE HealthCare that grants radiologists ‘anywhere access’
The U.S. Food and Drug Administration has cleared a next-generation image viewer that grants radiologists “anywhere access” to scans, manufacturer GE HealthCare announced Monday.
Leaders said the regulatory decision applies to GEHC’s View, a key piece of the Chicago-based company’s Genesis Radiology Workspace. The product is aimed at optimizing imaging workflows by letting radiologists work “virtually anywhere.”
It allows for 2D and 3D visualization alongside artificial intelligence tools and advanced-visualization applications, in one workflow.
“View is designed to meet radiologists wherever they are—providing secure, high‑performance access to diagnostic imaging through a truly cloud‑native experience,” Scott Miller, CEO of enterprise imaging solutions, said in a March 9 announcement. “By removing traditional infrastructure barriers, we’re enabling faster collaboration, greater flexibility, and more streamlined workflows across care teams.”
GEHC noted that the product comes with “zero footprint,” thanks to its utilization of the cloud. The announcement comes after GE HealthCare in November reached a deal to acquire Montreal-based imaging software provider Intelerad for $2.3 billion.
Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic.